iNDICA NEWS BUREAU–
Generative AI (GenAI) will free up to 10 per cent of clinicians’ time, translating into an estimated $100 billion in annual healthcare savings in Asia/Pacific excluding Japan (APEJ) by 2025, to realize more workflow automation and efficiency. This was the primary finding in a new report published by International Data Corporation (IDC) this past week.
By the end of 2027, driven by the demand to scale hyper-personalised patient experiences, improve collaboration, and foster equity, 60 per cent of Asia/Pacific healthcare organisations will double GenAI investments, according to the IDC report.
GenAI is emerging as a transformative force in healthcare and is set to impact workforce efficiency and hyper-personalisation in the care processes.
“With the advent of GenAI and the need for consumerization of care, the next five years are set to be the defining period for the healthcare sector, and we are currently at the starting point of this exciting journey,” said Manoj Vallikkat, senior research manager, healthcare insights, IDC Asia/Pacific.
Driven by the need for improved diagnostic accuracy, speed, and workflow efficiency, care providers in Asia/Pacific will see a 60 per cent increase in AI solution adoption by 2026.
By 2027, 50 per cent of the healthcare industry in Asia/Pacific will leverage GenAI to address data and workflow fragmentation across care settings to improve diagnosis and patient safety to scale care anywhere, the report mentioned.
By 2026, a doubling of hospital-at-home patients will propel a 55 per cent growth in investments in tech-enabled integrated care initiatives to address patient safety, workforce, and care access concerns in Asia/Pacific.
“In the healthcare sector, the unique risks associated with AI are significant, which necessitates a greater focus on explainability and data security,” added Vallikkat.
“Equitable healthcare has always been a big headache for the healthcare sector, but the evolution of technology, such as AI, will provide viable means to reduce the gaps in digital healthcare,” says Louise Francis, Head of Public Sector Research, IDC Asia/Pacific. “The emergence of the concept of ‘techquity’ highlights how technology will provide the bridge to enabling equitable access to healthcare services over the next five years”, said Francis.
In addition to the overarching theme of AI, the IDC predictions cover several other themes including industry clouds, Hospital@Home (H@H), “payvider” financing, integrated platforms, and the future of hospitals. Special attention has been given towards optimizing technology investments, with a particular emphasis on enhancing operational efficiency and elevating patient outcomes.
-
Industry Clouds: Driven by the perceived value of purpose-built functionalities for healthcare, 40% of healthcare organizations in Asia/Pacific will adopt industry clouds by 2025.
-
Payvider Financing: By 2026, 45% of Asia/Pacific private health insurance companies and 75% of U.S. health systems will be “payviders” to improve risk management and address the rising cost of care.
-
H@H: By 2026, a doubling of hospital-at-home patients will propel a 55% growth in investments in tech-enabled integrated care initiatives to address patient safety, workforce, and care access concerns in Asia/Pacific.
-
Techquity: By 2028, 60% of the healthcare industry in Asia/Pacific will prioritize tech partnerships that champion “techquity,” reducing the digital divide and recognizing social determinants of health as vital influencers.
-
Integrated Platforms: Personalized health data platforms will support 50% of covered patients in advanced economies by 2028 while building more accurate patient journey simulations for providers and life science companies in Asia/Pacific.
-
Future of Hospitals: By 2029, hospital investments in sustainability and modernization will increase by 50%, driven by the need to reduce costs, improve quality of care, and enhance organizational resiliency in Asia/Pacific.
